CK Life Sciences Int'l., (Holdings) Inc. (SEHK: 775)
Health Care · Biotechnology · HK
HK$0.52
-1.89% today · -46.9% 1Y
CK Life Sciences Int'l., (Holdings) Inc. (SEHK: 775) operates in the Biotechnology industry within the Health Care sector. The company is valued at $636.85M.
Over the last twelve months the share price has lost 46.9%, trading between 0.51 and 1.03.
Tweenvest scores CK Life Sciences Int'l., (Holdings) Inc. across four factors: quality 54/100, value 70/100, growth 5/100. Its strongest factor is value.
775 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $636.85M
- Revenue (TTM)
- $703.92M
- P/E
- —
- EPS
- -0.01
- Dividend yield
- —
- Beta (5Y)
- 0.45
- 52-week high
- HK$1.03
- 52-week low
- HK$0.51
- Avg volume (3M)
- —
- Shares outstanding
- 9.61B
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Abbisko Cayman LimitedSEHK: 2256 | $665.94M | HK$7.89 | -9.83% |
| Beijing Bohui Innovation Biotechnology Group Co., Ltd.SZSE: 300318 | $646.39M | CN¥5.30 | +1.34% |
| Crescent Biopharma, Inc.NasdaqCM: CBIO | $638.16M | $14.91 | +4.12% |
| Medigen Vaccine Biologics CorporationTPEX: 6547 | $637.45M | NT$62.00 | +1.97% |
| Elixiron Immunotherapeutics (Cayman) LimitedTPEX: 7871 | $634.12M | NT$151.00 | -1.95% |
| Sagimet Biosciences Inc.NasdaqGM: SGMT | $633.21M | $8.93 | -2.30% |
| Climb Bio, Inc.NasdaqGM: CLYM | $631.80M | $11.00 | +0.55% |
| Ironwood Pharmaceuticals, Inc.NasdaqGS: IRWD | $631.22M | $3.82 | -1.29% |
Figures last refreshed Oct 11, 2026.